Fmoc-3,4-Difluoro-D-Phenylalanine

Fmoc-3,4-Difluoro-D-Phenylalanine is a D-configured, aromatic amino acid derivative in which the phenyl ring bears two fluorine substituents at the 3 and 4 positions and the α-amino group is protected as an Fmoc carbamate. The molecule combines a stereodefined chiral center with an activated carboxylic acid handle suitable for peptide coupling and a strongly electron-withdrawing difluorophenyl motif that can modulate conformational preferences and side-chain polarity during structure-function studies. The Fmoc group supports base-labile deprotection under standard solid-phase or solution peptide synthesis conditions, enabling sequential chain assembly while preserving the D-configuration at the α-carbon. The difluoro-substituted aromatic side chain can participate in halogen-influenced binding interactions and can serve as a chemically stable, fluorinated fragment for downstream medicinal chemistry, peptidomimetic, and analytical applications.

1. Peptide Synthesis

Fmoc-3,4-Difluoro-D-Phenylalanine is used as a protected amino acid building block for peptide coupling in solid-phase and solution-phase workflows where Fmoc chemistry enables controlled N-terminal assembly. The Fmoc-protected amino group and carboxyl functionality support amide-bond formation with activated carboxylic acid derivatives, while the D-stereochemistry provides a stereochemically defined residue for peptide stereocontrol. The 3,4-difluorophenyl side chain can be incorporated to introduce halogenated aromatic character that may influence peptide secondary structure propensity and binding-site complementarity. The resulting fluorinated peptides and peptide analogs can be applied in peptide library construction, SAR-focused analog generation, and mechanistic studies requiring precise stereochemical placement of a difluorophenyl residue.

2. Peptidomimetics And SAR

Fmoc-3,4-Difluoro-D-Phenylalanine serves in peptidomimetic design and structure-activity relationship studies where the difluorinated phenyl ring functions as a tunable pharmacophore-like element. The aromatic side chain with two fluorine atoms increases electron-withdrawing character and can alter hydrophobicity, polarizability, and potential halogen-bonding patterns relative to unsubstituted phenylalanine derivatives. The D-configuration can be leveraged to probe stereochemical effects on receptor or enzyme recognition, while the Fmoc handle allows incorporation into longer scaffolds before further derivatization. Downstream use can include generating fluorinated analog panels for medicinal chemistry screening support, mapping binding determinants, and preparing defined intermediates for subsequent side-chain functional transformations.

3. Chemical Biology Labeling

Fmoc-3,4-Difluoro-D-Phenylalanine is applicable to chemical biology workflows that require incorporation of a fluorinated amino acid residue into biomolecule constructs for detection, affinity probing, or residue-specific modification. The protected amino acid format supports stepwise assembly into peptides or peptide conjugates, and the difluorophenyl side chain can serve as a stable structural tag that may be detectable by mass spectrometry and can modulate local microenvironment interactions. The Fmoc group enables clean N-terminal deprotection during synthesis, facilitating conjugation strategies that depend on exposing a reactive peptide terminus or maintaining a defined residue position for subsequent coupling. The resulting fluorinated peptide probes can be used to interrogate binding interfaces, evaluate substrate recognition motifs, or generate defined standards for analytical characterization of labeled biomolecule fragments.

4. Chiral Amino Acid Intermediate

Fmoc-3,4-Difluoro-D-Phenylalanine is used as a chiral amino acid intermediate in fine chemical synthesis where D-configuration and difluorinated aromatic substitution are key structural requirements. The stereogenic α-carbon and the Fmoc-protected amine provide a protected, isolable form that can be carried through multi-step synthetic sequences before incorporation into peptide-like structures or conversion into other N-functional derivatives. The carboxyl functionality can be transformed into activated intermediates for coupling chemistry, while the difluorophenyl motif can remain intact as a chemically robust fragment during downstream synthetic operations. This intermediate role supports the preparation of fluorinated chiral building blocks for medicinal chemistry campaigns, stereochemically defined peptide fragments, and process-oriented intermediate supply for specialty chemical production.

5. Pharmaceutical Manufacturing Intermediates

Fmoc-3,4-Difluoro-D-Phenylalanine is suitable for pharmaceutical manufacturing-oriented peptide intermediate preparation where Fmoc-based protection aligns with scalable peptide synthesis logic and controlled deprotection steps. The Fmoc carbamate and the carboxyl group enable reproducible coupling chemistry to form amide linkages, while the D-configuration and difluorinated aromatic side chain allow consistent incorporation of stereochemically defined residues into drug-like peptide candidates or peptide excipients. The electron-withdrawing difluoro substituents can support molecular design constraints that require stable fluorinated aromatic fragments without introducing additional reactive handles that complicate purification. Downstream utility includes producing defined, fluorinated peptide intermediates for further synthetic elaboration, analytical method development, and manufacturing feedstock generation for peptide-based chemical entities.

1. C-peptide and its C-terminal fragments improve erythrocyte deformability in type 1 diabetes patients

2. Extended exenatide administration enhances lipid metabolism and exacerbates pancreatic injury in mice on a high fat, high carbohydrate diet

3. Effect of Short-Term Desiccation, Recovery Time, and CAPA-PVK Neuropeptide on the Immune System of the Burying Beetle Nicrophorus vespilloides

4. Cationic cell-penetrating peptides are potent furin inhibitors

5. Tachykinin-related peptides modulate immune-gene expression in the mealworm beetle Tenebrio molitor L